Democratizing Organ-On-A-Chip Technology

Watch this featured session from Boston MPS Day where Luke Dimasi, Senior Director, Product Management, Emulate discusses the evaluation of chimeric antigen receptor (CAR) CAR T-Cell therapy recruitment and efficacy with Organ-on-a-Chip technology. Learn about CAR T-cell therapy as a promising cancer treatment, challenges in CAR T development for solid tumors, why 2D cell models fall short for researchers studying CAR T-cells, the advantages of modeling the holistic CAR T journey with Organ-Chips, and more.